Area of research
Oncology · Virology
Research interest
Research interests include HIV Research and Treatment, Chemokine receptors and signaling, Cancer Immunotherapy and Biomarkers, and Immune Cell Function and Interaction.
Identifying pre-treatment risk factors for cancer-related cognitive decline in patients with breast cancer
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Pregnancy After Breast Cancer in Young <i>BRCA </i>Carriers
Cancer and Aging: Two Tightly Interconnected Biological Processes
Is cancer biology different in older patients?
Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
Computerised scoring protocol for identification and quantification of different immune cell populations in breast tumour regions by the use of QuPath software
Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
Biological ageing and frailty markers in breast cancer patients
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
Evaluating the physiological reserves of older patients with cancer: The value of potential biomarkers of aging?
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency
The role of genetic breast cancer susceptibility variants as prognostic factors
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2